External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia
Background: Methotrexate (MTX) is a key immunosuppressant for children with acute lymphoid leukemia (ALL), and it has a narrow therapeutic window and relatively high pharmacokinetic variability. Several population pharmacokinetic (PopPK) models of MTX in ALL children have been reported, but the vali...
Main Authors: | , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
MDPI AG
2023-02-01
|
丛编: | Pharmaceutics |
主题: | |
在线阅读: | https://www.mdpi.com/1999-4923/15/2/569 |